251 related articles for article (PubMed ID: 6387355)
1. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
[TBL] [Abstract][Full Text] [Related]
2. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
3. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
Hyttel J; Arnt J
J Neural Transm; 1987; 68(3-4):171-89. PubMed ID: 2881976
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
6. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
[TBL] [Abstract][Full Text] [Related]
7. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
Flaim KE; Gessner GW; Crooke ST; Heys JR; Weinstock J
Life Sci; 1986 Jun; 38(23):2087-96. PubMed ID: 2872567
[TBL] [Abstract][Full Text] [Related]
8. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
Cross AJ; Mashal RD; Johnson JA; Owen F
Neuropharmacology; 1983 Nov; 22(11):1327-9. PubMed ID: 6141534
[TBL] [Abstract][Full Text] [Related]
9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
10. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
11. Striatal D1- and D2-dopamine receptor sites are separately detectable in vivo.
Leslie CA; Bennett JP
Brain Res; 1987 Jul; 415(1):90-7. PubMed ID: 2957025
[TBL] [Abstract][Full Text] [Related]
12. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
Andersen PH; Braestrup C
J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
[TBL] [Abstract][Full Text] [Related]
13. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
14. Absence of [3H]SCH 23390 binding sites in the rat adrenal gland.
Zdilar D; Lacković Z
J Pharm Pharmacol; 1989 Sep; 41(9):646-8. PubMed ID: 2573713
[TBL] [Abstract][Full Text] [Related]
15. [3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
McQuade RD; Duffy RA; Anderson CC; Crosby G; Coffin VL; Chipkin RE; Barnett A
J Neurochem; 1991 Dec; 57(6):2001-10. PubMed ID: 1834801
[TBL] [Abstract][Full Text] [Related]
16. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
Gredal O; Nielsen M; Hyttel J
Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
[TBL] [Abstract][Full Text] [Related]
17. Binding of [3H]SCH 23390 to dopamine D-1 receptors in rat retina in vitro.
Gredal O; Parkinson D; Nielsen M
Eur J Pharmacol; 1987 Jun; 137(2-3):241-5. PubMed ID: 2886353
[TBL] [Abstract][Full Text] [Related]
18. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
Zhang X; Segawa T
Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
[TBL] [Abstract][Full Text] [Related]
19. [3H]SCH 23390 identifies D-1 binding sites in rat striatum and other brain areas.
Kilpatrick GJ; Jenner P; Marsden CD
J Pharm Pharmacol; 1986 Dec; 38(12):907-12. PubMed ID: 2880965
[TBL] [Abstract][Full Text] [Related]
20. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
